Elanco Animal Health Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 21, 2025, reports on the appointment of a new Chief Financial Officer (CFO) and the transition of the outgoing CFO. The filing was signed on May 28, 2025, by Shiv O'Neill, Executive Vice President, General Counsel, and Corporate Secretary.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation and employment terms.
Material Changes
The primary material change is the leadership transition in the finance function:
- Appointment: Robert (Bob) VanHimbergen is appointed as Executive Vice President and Chief Financial Officer, effective July 7, 2025.
- Departure: Todd Young will step down as CFO but will serve as a non-executive advisor through August 31, 2025.
Management Commentary, Risks, and Unusual Items
Compensation for New CFO (Robert VanHimbergen):
- Base Salary: $660,000 annually.
- Cash Incentive: Target of 75% of base salary (pro-rated for fiscal 2025).
- Long-Term Incentive (LTI): Target value of $2,645,000 annually. For fiscal 2025, the pro-rated value is $1,100,000, split equally between restricted stock units (RSUs) and stock options, vesting ratably over three years.
- Make-Whole Awards:
- Cash bonus of $890,000 (subject to repayment clawback if employment ends within three years for reasons other than involuntary termination without cause).
- RSU grant with a fair value of $1,735,000, vesting ratably over three years.
Transition Arrangements for Outgoing CFO (Todd Young):
- Continues to receive current compensation during the advisory period through August 31, 2025.
- Eligible for full-year fiscal 2025 annual cash incentive based on company performance.
- Accelerated vesting of a pro-rata portion of unvested RSUs, stock options, and performance awards.
- Extension of stock option expiration date to December 31, 2026.
- Eligible for severance benefits under the Executive Severance Pay Plan after the transition period.
Investor Verification Checklist
- Verify the effective start date of Robert VanHimbergen (July 7, 2025) and the end date of Todd Young's advisory role (August 31, 2025).
- Review the attached Employment Offer Letter (Exhibit 10.1) for specific vesting schedules and performance metrics for the new CFO's LTI.
- Confirm the repayment terms for the $890,000 make-whole cash bonus in the event of early departure.
- Assess the impact of the accelerated vesting and option extension for Todd Young on future equity dilution.